I’ve spent 11 patient assistance programs conference reviews years in commercial operations and managed markets. If I had a dollar for every time someone told me a conference offered "great networking," I’d have retired to a private island years ago. Networking is a vanity metric. If you can’t name the specific titles of the people you met and what their immediate pain point is, you didn't network; you just collected business cards that will sit in a drawer until they’re recycled.
I keep a spreadsheet for every event. Column A is the attendee, Column B is their actual decision-making power, and Column C is "Who they actually report to." If you’re tired of wasting your Q4 budget on events that yield zero formulary movement, this guide is for you.
The Landscape: Understanding Your Target
Before you register, define your objective. Is this for market access, or are you trying to sway prescribers? If you’re at a PBM-heavy event but your drug is a niche orphan specialty med that requires a white-glove health system hand-off, you’re in the wrong room.
Here is how I stack up the big hitters in the industry:
Conference Primary Audience Best For AMCP Nexus Payer pharmacists, PBM decision-makers Formulary strategy & policy updates The Health Management Academy (THMA) Health system C-suite, GPO executives Integrated delivery network (IDN) strategy Association of Cancer Care Centers (ACCC) Oncology program directors, providers Clinical execution & patient access1. AMCP Nexus: The Managed Care Pharmacy Standard
If your job involves pharmacy benefit managers (PBMs) or health plan formulary placement, AMCP Nexus managed care sessions are non-negotiable. This is where the technical, clinical, and economic dossiers intersect.
Why it works: You aren't just meeting "people"; you are meeting the clinical pharmacists who sit on the P&T committees. They care about evidence generation. They want to see your data, and they want to see it in a format that mirrors their own digital tools for evidence review.
Pro-tip: When you're on the expo floor or in the breakout rooms, pay attention to the digital tools being demonstrated. If a vendor is showing off a platform that integrates into their P&T workflow, that is a high-signal area. Ignore the buzzwords. Look for the API integration capability.
2. The Health Management Academy (THMA): The C-Suite Play
When you stop selling "the drug" and start selling "the health system partnership," you go to THMA. This is for the executive roundtables. You won't find low-level PBM analysts here. You find health system executives who are sweating over HTA (Health Technology Assessment) pressure and pricing.
They aren't interested in your "synergy." They want to know how your product affects their bottom line—specifically, the cost of administration vs. the reimbursement reality. If you can’t articulate your value proposition in terms of institutional cost-avoidance, don't bother registering.
3. Association of Cancer Care Centers (ACCC): Clinical Execution
For specialty oncology products, ACCC is where the rubber meets the road. It’s less about the PBM contract and more about the hospital’s ability to execute a complex care plan. If your drug requires specific site-of-care requirements or complex billing, this is where you find the people who actually handle clinical operations market access alignment the day-to-day reimbursement hurdles.
The "Monday Morning" Test
I have one rule for every conference I attend: What am I doing differently on Monday? If you leave a health plans conference without a tangible list of "Must-Fix" items, you wasted the company's money.
Three things to do immediately upon returning:
- Review the "Who I Actually Met" spreadsheet: Did you capture the specific hurdle they mentioned? If they mentioned a specific barrier to formulary adoption, that’s your homework for the next P&T cycle. Audit your digital presence: I noticed a lot of companies have websites with terrible UI, including broken or annoying Cookie Law Info plugin elements that block the very content they are trying to share with payers. If a payer is trying to access your portal and gets stuck in a modal loop, you’ve lost them. Fix it. Clean your data: Ensure the evidence generation tools you showcased are actually accessible to the people you talked to. If you promised a dossier, send it by Tuesday morning.
Addressing the Buzzword Problem
I am tired of hearing about "streamlining" and "synergy." They mean nothing. In managed care, the only thing that matters is access and affordability. PBMs are under massive scrutiny regarding transparency. Health plans are struggling with HTA pressure as high-cost gene therapies hit the market.
If your presentation or your pitch at these conferences uses these buzzwords, you sound like a vendor trying to hide a weak product. Be blunt. If your price is high, explain why the clinical outcome creates a net-zero impact on the payer's total cost of care. If you can’t explain it, you haven’t done your homework.
Final Thoughts: Don't Be a Tourist
Too many people treat these conferences like a paid vacation. They sit in the back of the room, scroll LinkedIn, and say they "networked."
Here is my challenge to you: Next time you attend an AMCP Nexus or similar event, pick three accounts you *know* are struggling with your product’s coverage. Find out who is attending from those specific organizations. Find out what they are actually presenting on. If they aren't presenting, look at the panel they are attending. Meet them there. Don't sell. Ask: "How is your team handling the current HTA pressure?"
That is how you turn a generic conference into a strategic win. Everything else is just expensive noise.